Hepatitis C virus genotype 4 and response to combination therapy with interferon-α2b plus ribavirin

被引：4
|
作者：
Bruno, S [1 ]
Crosignani, A
Pinzello, GB
机构：
[1] S Paolo Univ Milan, I-20142 Milan, Italy
[2] Crespi Niguarda Hosp Milan, Liver Unit, I-20100 Milan, Italy
来源：
ANNALS OF INTERNAL MEDICINE | 2000年 / 133卷 / 11期
关键词：
D O I：
10.7326/0003-4819-133-11-200012050-00025
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：922 / 923
页数：2
相关论文
共 50 条
  • [31] Effect of combination therapy with ribavirin and high-dose interferon-α2b for 24 weeks in chronic hepatitis C
    Abe, S
    Narita, R
    Oto, T
    Tabaru, A
    Otsuki, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (01) : 308 - 312
  • [32] Efficacy of hepatitis B vaccination and interferon-α-2b combination therapy versus interferon-α-2b monotherapy in children with chronic hepatitis B
    Helvaci, M
    Kizilgunesler, A
    Kasirga, E
    Ozbal, E
    Kuzu, M
    Sozen, G
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (07) : 785 - 791
  • [33] Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus
    Hashimoto, Yuki
    Kanto, Hiromi
    Itoh, Masatoshi
    JOURNAL OF DERMATOLOGY, 2007, 34 (08): : 577 - 582
  • [34] Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C
    Ishiguro, Haruya
    Abe, Hiroshi
    Seki, Nobuyoshi
    Sugita, Tomonori
    Aida, Yuta
    Itagaki, Munenori
    Sutoh, Satoshi
    Shimada, Noritomo
    Furihata, Tomomi
    Tsubota, Akihito
    Aizawa, Yoshio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (13) : 3904 - 3911
  • [35] Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C
    Haruya Ishiguro
    Hiroshi Abe
    Nobuyoshi Seki
    Tomonori Sugita
    Yuta Aida
    Munenori Itagaki
    Satoshi Sutoh
    Noritomo Shimada
    Tomomi Furihata
    Akihito Tsubota
    Yoshio Aizawa
    World Journal of Gastroenterology, 2015, (13) : 3904 - 3911
  • [36] Interferon-β plus ribavirin for patients with hepatitis C virus genotype 1:: a randomised pilot trial
    Enomoto, M
    Tamori, A
    Kawada, N
    Jomura, H
    Nishiguchi, S
    Saibara, T
    Onishi, S
    Mochida, S
    Fujiwara, K
    GUT, 2006, 55 (01) : 139 - 140
  • [37] Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus
    Tamai, Hideyuki
    Shingaki, Naoki
    Mori, Yoshiyuki
    Moribata, Kosaku
    Kawashima, Akira
    Maeda, Yoshimasa
    Niwa, Toru
    Deguchi, Hisanobu
    Inoue, Izumi
    Maekita, Takao
    Iguchi, Mikitaka
    Kato, Jun
    Ichinose, Masao
    GUT AND LIVER, 2016, 10 (04) : 617 - 623
  • [38] MUTATIONS IN THE NS5A REGION OF HEPATITIS C VIRUS GENOTYPE 2A AND CORRELATION WITH RESPONSE TO PEGYLATED-INTERFERON-ALPHA 2B AND RIBAVIRIN COMBINATION THERAPY
    Hayashi, Kazuhiko
    Katano, Yoshiaki
    Ishigami, Masatoshi
    Nakano, Isao
    Goto, Hidemi
    HEPATOLOGY, 2009, 50 (04) : 677A - 677A
  • [39] PRETREATMENT SERUM PAI-1 LEVEL IS A NOVEL PREDICTOR FOR RESPONSE TO PEGYLATED INTERFERON-α-2B PLUS RIBAVIRIN THERAPY IN CHRONIC HEPATITIS C VIRUS INFECTION
    Miki, Daiki
    Ohishi, Waka
    Ochi, Hidenori
    Hayes, C. Nelson
    Abe, Hiromi
    Hayashida, Yasufumi
    Tsuge, Masataka
    Imamura, Michio
    Kamatani, Naoyuki
    Nakamura, Yusuke
    Chayama, Kazuaki
    HEPATOLOGY, 2011, 54 : 821A - 821A
  • [40] Polymorphism in the NS3 region in patients with hepatitis C virus genotype 1B and response to telaprevir or simeprevir plus pegylated-interferon-alpha 2b and ribavirin combination therapy
    Yoshizaki, Michiyo
    Hayashi, Kazuhiko
    Mori, Hiroshi
    Toriyama, Kazuhiro
    Furune, Satoshi
    Takenaka, Hiroyuki
    Matuura, Tetuo
    Shimizu, Yuko
    Hayashi, Takao
    Kuroiwa, Masanori
    Morita, Keiichi
    Ishigami, Masatoshi
    Goto, Hidemi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 210 - 210
12345